insights_auto
Nega YP2 tushdi 14,52%?
Batafsil oʻrganishchevron_right
YP2:FRA
BioLine RX Ltd - ADR
0,80 €
arrow_downward
-14,52%(-0,13) 1K
17-noy, 8:04:30 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoYP2 tikeri uchun statistika yaratilmoqda...
Ochish
0,80 €
Yuqori
0,80 €
Past
0,80 €
Bozor kapitali
9,20 mln
Oʻrtacha hajm
27,00
Hajmi
0,00
52 haftalik eng yuqori
3,26 €
52 haftalik eng past
0,80 €
Xodimlar soni
22
Ochish
0,80 €
Yuqori
0,80 €
Past
0,80 €
Bozor kapitali
9,20 mln
Oʻrtacha hajm
27,00
Hajmi
0,00
52 haftalik eng yuqori
3,26 €
52 haftalik eng past
0,80 €
Xodimlar soni
22
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com
·
1 kun oldin
BioLineRx initiates fourth cohort in GLIX1 brain tumor trial
Profil
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
BioLine RX Ltd - ADR haqida
CEOPhilip A. Serlin
Xodimlar soni22
Asos solingan2003
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytbiolinerx.com